Pancreatic cancer: Advances and challenges

Halbrook, Christopher J., Lyssiotis, Costas A., Pasca di Magliano, Marina, Maitra, Anirban·2023·Cell
DOI 10.1016/j.cell.2023.02.014

Cited by (999)

Items 601–700 of 999

  1. Asynchronous Evolution of Epithelium and Stroma Differentiates Precursor Lesions from Pancreatic Cancer
    Ahmed M. Elhossiny, Padma Kadiyala, Jude Ogechukwu Okoye, Harrison L. Hiraki, Megan C. Procario, Thejaswini Giridharan, Hannah R. Watkoske, Mariana T. Ruckert, Jiayue Wang, Brian D. Griffith et al. · 2026 · Cancer Discovery
  2. BCL2A1 neoepitope–elicited cytotoxic T lymphocytes are a promising individualized immunotherapy of pancreatic cancer
    Shengzhe Lin, Jingwen Hong, Suxin Wu, Chenlu Zhu, Fang Liu, Wansong Lin, Xinran Cai, Yunbin Ye, Yanling Chen · 2024 · Journal of Leukocyte Biology
  3. A machine learning model based on clinical features and ultrasound radiomics features for pancreatic tumor classification
    Shunhan Yao, Dunwei Yao, Yuanxiang Huang, Shanyu Qin, Qingfeng Chen · 2024 · Frontiers in Endocrinology
  4. Combined Efficacy of Nimotuzumab and Gemcitabine on the Treatment of Advanced Pancreatic cancer
    Yi Li, Dan Li, Qianqian Liu, Jun Li · 2024 · Pancreas
  5. Identified γ-glutamyl cyclotransferase (GGCT) as a novel regulator in the progression and immunotherapy of pancreatic ductal adenocarcinoma through multi-omics analysis and experiments
    Ying Zheng, Qunli Xiong, Yang Yang, Yifei Ma, Qing Zhu · 2024 · Journal of Cancer Research and Clinical Oncology
  6. Prediction of synergistic gemcitabine-based combination treatment through a novel tumor stemness biomarker NANOG in pancreatic cancer
    Jiongjia Cheng, Ting Zhu, Shaoxian Liu, Jiayu Zhou, Xiaofeng Wang, Guang‐Xiang Liu · 2024 · RSC Medicinal Chemistry
  7. Identification of M2 macrophage-related genes for establishing a prognostic model in pancreatic cancer: FCGR3A as key gene
    Zhen Wang, JUN FU, SAISAI ZHU, Haibo Tang, Kui Shi, JIHUA YANG, Meng Wang, MENGGE WU, Dunfeng Qi · 2024 · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
  8. MSI-H Detection by ddPCR in Endoscopic Ultrasound Fine Needle Biopsy (EUS-FNB) from Pancreatic Ductal Adenocarcinoma
    Maria Assunta Piano, Elisa Boldrin, Lidia Moserle, Nicoletta Salerno, Dalila Fanelli, Giulia Peserico, Maria Raffaella Biasin, Giovanna Magni, Veronica Varano, Giorgia Zalgelli et al. · 2024 · International Journal of Molecular Sciences
  9. Pancreas Segmentation Using SRGAN Combined with U-Net Neural Network
    Mayra Tualombo, Iván Reyes, Paulina Vizcaíno-Imacaña, Manuel Eugenio Morocho-Cayamcela · 2024 · Communications in computer and information science
  10. Exploring SLC30A6 as a potential prognostic, immunomodulatory, and therapeutic biomarker in various cancers with a focus on pancreatic cancer: a pan-cancer analysis
    Fatemeh Maghool, Parisa Kadkhodaei Elyaderani, Samaneh Mohammadzadeh, Amir Hosseini, Aida Heidari, Pouria Samadi · 2024 · Egyptian Journal of Medical Human Genetics
  11. The global progress and quality assessment of research on the association between circulating tumor DNA and clinical prognosis: a systematic review
    Meng Zhang, Xiaowei Chen, Qingxin Zhou, Nana Guo, Baoshan Cao, Hongmei Zeng, Wanqing Chen, Feng Sun · 2024 · Journal of the National Cancer Center
  12. A Comprehensive Review of Phytochemistry and Anticancer of the Genus Goniothalamus
    Fan Xie, Zilong Zhang, Xiuqin Zheng, Yiming Li, Rui Wang, Wen‐Yan Li · 2025 · Chemistry & Biodiversity
  13. Small-molecule inhibitor BAY synergizes with gemcitabine through AHR inhibition in pancreatic cancer cells
    Darius Stukas, Inga Žievytė, Sandra Ivanauskienė, Gabrielė Karvelytė, Aldona Jasukaitienė, Arenida Bartkevičienė, Jason B. Matthews, Toivo Maimets, Indrek Teino, Kristaps Jaudzems et al. · 2025 · Biochemical Pharmacology
  14. RNA binding protein Pumilio2 promotes chemoresistance of pancreatic cancer via focal adhesion pathway and interacting with transcription factor EGR1
    Zhao Bangbo, Cheng Qin, Li Zeru, Yuanyang Wang, 杨晓莹, Tianyu Li, Zhao Yu-Pei, Weibin Wang, Zhao Yu-Pei · 2025 · Cellular and Molecular Life Sciences
  15. Interaction of Avapritinib with Congo Red in Pancreatic Cancer Cells: Molecular Modeling and Biophysical Studies
    Małgorzata Lasota, Daniel Jankowski, Anna Wiśniewska, Łukasz Szeleszczuk, Anna Misterka, Marta Kaczor-Kamińska, Marta Zarzycka, Maksym Patena, Tomasz Brzozowski · 2025 · International Journal of Molecular Sciences
  16. Crosstalk of TGF-β and somatostatin signaling in adenocarcinoma and neuroendocrine tumors of the pancreas: a brief review
    Hendrik Ungefroren, Harpal Singh Randeva, Hendrik Lehnert, Joerg Schrader, Jens Uwe Marquardt, Björn Konukiewitz, Ralf Hass · 2025 · Frontiers in Endocrinology
  17. The value of preoperative RDW for post-pancreatectomy haemorrhage and surgical prognosis in patients with pancreatic cancer: a retrospective study
    Ting Niu, Yueying Wang, Liangliang Lu, Jialin Li, Tianhua Cheng, Yuanqiang Dai · 2025 · BMC Cancer
  18. Spatially Controlled Co‐Delivery of Diagnostic and Therapeutic Agents Using DNA Nanoframeworks for Pancreatic Cancer Precision Therapy
    Nachuan Song, Ruoyu Tao, Hongjin Li, Rui Zhang, Yan Hao Huang, Le Zhang, Ying Liu, Dayong Yang, Chi Yao · 2025 · Angewandte Chemie
  19. Non-hypervascular pancreatic neuroendocrine neoplasms differentiation from CA19-9 negative pancreatic ductal adenocarcinomas based on contrast CT: A large sample series
    Jinyin Zhang, Qingquan Tan, Fan Yang, Liu Xiao, Zhenjiang Zheng, Keyu Li, Wenyi Jing, Haiyu Song, Xu-Bao Liu, Chunlu Tan et al. · 2025 · European Journal of Radiology
  20. Induced mitochondrial deficit by NDUFS3 transient silencing reduces RAB7 expression and causes lysosomal dysfunction in pancreatic cancer cells
    Giulia Girolimetti, Sinforosa Gagliardi, Paola Cordella, Grazia Bramato, Riccardo Di Corato, Roberta Romanò, Flora Guerra, Cecilia Bucci · 2025 · Cell Communication and Signaling
  21. Advances in AI-driven applications of metal-organic frameworks for the diagnosis and treatment of pancreatic cancer
    Chun-Yue Shi, Geqi Chen, Min Ye, Ziqi Xia, Yanna Ye, Aparna Kushwaha, Jun Wang, Abhinav Kumar, Ying H. Pan · 2025 · Dyes and Pigments
  22. PRRX2 Regulates GLI2 to Promote Proliferation, Invasion, and Metastasis by Inhibiting Senescence via Hedgehog Signaling
    Wei Huang, Feifei Xu, Jichuan Xu, Gang Quan, Shihang Zhang, Mengmeng Guo, Feng xiao, Jianxin Jiang · 2025 · Cancer Science
  23. Intraductal Papillary Mucinous Neoplasm and Pancreatic Cancer: Opportunity Knocks Twice
    Tsuyoshi Hamada, Hiroki Oyama, Yousuke Nakai, Maxim S. Petrov, for the TOP-CREATE study group · 2025 · The American Journal of Gastroenterology
  24. Organoids in the research of pancreatic neoplasms: cultivation, applications, and limitations
    Changwei Du, Yueze Liu, Xiaoyue Lu, Menggang Zhang, Shijuan Jiang, Zhe Cao, Gang Yang, Jiangdong Qiu, Taiping Zhang, Yupei Zhao · 2025 · Cancer Letters
  25. Intermediate Conductance Calcium‐Dependent Potassium Channel (K Ca 3.1) Interacting Proteins Using Turboid‐Based Proximity Labeling Technology: Insights Into Interactome and Related Signaling Pathways in Pancreatic Tumors
    Veronica Carpanese, Soha Sadeghi, Luca Matteo Todesca, Ildikò Szabó, Vanessa Checchetto · 2025 · Journal of Cellular Physiology
  26. KRAS-induced STN1 (OBFC1) promotes proper CTC1–STN1–TEN1 complex-independent DNA double-strand break repair and cell cycle checkpoint maintenance in pancreatic cancer
    Changxian Shen, Tiantian Cui, Linlin Yang, Ling Gui, Sergio Corrales-Guerrero, Sindhu Nair, Haiqing Li, Joanna M. Karasinska, James Thomas Topham, Daniel John Renouf et al. · 2025 · Nucleic Acids Research
  27. A GPC1-Targeting multifunctional nanoplatform combining paclitaxel-mediated chemotherapy and chlorin e6-assisted sonodynamic therapy for Pancreatic Ductal Adenocarcinoma (PDAC) treatment
    Bo Ren, Han-mei Li, Ju-ying Zhang, Jiawei Wang, You Yang, Li-tao Ye, Jinhong Yu, Jian Xu, Gang Quan, Jingdong Li et al. · 2026 · Cancer Treatment and Research Communications
  28. Long non-coding RNA SNHG17 contributes to the progression of pancreatic adenocarcinoma by modulating miR-32-5p/EZH2/STAT3 signaling
    Liping Ying, Jinbo Wang, Ji-Ye Feng, Zongyang Wu · 2023 · Molecular Biology Reports
  29. Mass spectrometry–based proteomics technology in pancreatic cancer research
    Xue Jun Sun, Siyuan Wang, Catherine C. L. Wong · 2023 · Journal of Pancreatology
  30. PSCA is a critical biomarker for predicting the prognosis of KRAS/TP53 mutant pancreatic cancer patients
    Mengyuan Gong, Bo Zhang, Xueni Wang, Zeen Zhu, Wei Li, Liang Han, Zheng Wu, Qingyong Ma, Zheng Wang, Weikun Qian · 2023 · Journal of Pancreatology
  31. Down-regulation of microRNA-23a promotes pancreatic ductal adenocarcinoma initiation and progression by up-regulation of FOXM1 expression
    Lixin Liang, Tian Cai, Xiaojia Li, Jianhong An, Sen Yu, Yang Zhang, Fengjie Guo, Fang Wei, Jie He, Keping Xie et al. · 2023 · Genes & Diseases
  32. Excavation of gene markers associated with pancreatic ductal adenocarcinoma based on interrelationships of gene expression
    Zhao‐Yue Zhang, Zi‐Jie Sun, Dong Gao, Yu‐Duo Hao, Hao Lin, Fen Liu · 2024 · IET Systems Biology
  33. Comprehensive analysis of disulfidptosis-related lncRNAs for predicting prognosis and response of immunotherapy in pancreatic adenocarcinoma
    Junheng Guo, Yuyao Wang, Jingyu Hou, Tingshuo Zhao, Zhigang Wei · 2024 · Translational Cancer Research
  34. Biological impact and therapeutic potential of a novel camptothecin derivative (FLQY2) in pancreatic cancer through inactivation of the PDK1/AKT/mTOR pathway
    Wenchao Wang, Haonan Xiong, Lei Li, 胡霞林, Xialin Hu, Jiangtao Li, Xuanrong Sun, Yanlei Yu, Yuanquan Yu, Yanlei Yu et al. · 2024 · Bioorganic Chemistry
  35. SCANPatient: study protocol for a multi-centre, batched, stepped wedge, comparative effectiveness, randomised clinical trial of synoptic reporting of computerised tomography (CT) scans assessing cancers of the pancreas
    Lin Li, Jessica Kasza, Ariadna Recasens, Liane Ioannou, Elysia Greenhill, Neil Donald Merrett, David Cavallucci, Samantha J. Ellis, Helen Madgwick, Hyun Soo Ko et al. · 2024 · Trials
  36. Association of stromal type IV collagen and prognosis in neoadjuvant chemotherapy-treated pancreatic cancer
    Yasuhiro Nakamura, Takehiro Yasukawa, Yuki Fukumura, Yoshinori Takeda, Hiroshi Imamura, Yang Shi, Mu Li, Masaaki Abe, Saya Uyama, Kazunori Kajino et al. · 2024 · Japanese Journal of Clinical Oncology
  37. Identification and Validation of Senescence-Related Signature by Combining Single Cell and Bulk Transcriptome Data Analysis to Predict the Prognosis and Identify the Key Gene CAV1 in Pancreatic Cancer
    Liang Chen, Xiaomei Ying, Haohao Wang, Jiaheng Xie, Qikai Tang, Wen Liu · 2024 · Journal of Inflammation Research
  38. Primary and Metastatic Pancreatic Ewing Sarcomas: A Case Report and Review of the Literature
    Nektarios I. Koufopoulos, Menelaos G. Samaras, Christakis Kotanidis, Konstantinos Skarentzos, Abraham Pouliakis, Ioannis Boutas, Adamantia Kontogeorgi, Magda Zanelli, Andrea Palicelli, Maurizio Zizzo et al. · 2024 · Diagnostics
  39. Comparison of Shared Class I HLA-Bound Noncanonical Neoepitopes between Normal and Neoplastic Tissues of Pancreatic Adenocarcinoma
    Tengyi Zhang, Betul Celiker, Yingkuan Shao, Jessica Gai, C. Mark Hill, Chunyu Wang, Lei Zheng · 2024 · Clinical Cancer Research
  40. Predictive value of perioperative fasting blood glucose for post pancreatectomy diabetes mellitus in pancreatic ductal carcinoma patients
    Shuai Wang, Hanshen Zhou, Kaili Cai, Yiqun Fan, Xiaohui Yang, Bo Zhang, Yulian Wu · 2025 · World Journal of Surgical Oncology
  41. Targeting siRNA nanoparticles with ApoB peptide: Formulation, biodistribution, and bioactivity in pancreatic tumor-bearing mice
    Majd Agbaria, Doaa Jbara-Agbaria, Gershon Golomb · 2025 · Journal of Drug Delivery Science and Technology
  42. Finding patterns in lung cancer protein sequences for drug repurposing
    Belén Otero-Carrasco, Paloma Tejera Nevado, Rafael Artiñano Muñoz, Gema Díaz Ferreiro, Aurora Pérez, Juan Pedro Caraça-Valente Hernández, Alejandro Rodríguez‐González · 2025 · PLoS ONE
  43. Netrin G1 Ligand is a new stromal immunomodulator that promotes pancreatic cancer
    Debora Barbosa Vendramini Costa, Ralph Francescone, Janusz Franco‐Barraza, Tiffany Luong, Myree Graves, Ariana Musa de Aquino, Nina G. Steele, Jaye C. Gardiner, Sérgio Alexandre Alcântara dos Santos, Charline Ogier et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  44. MRTX1133’s promise for treating KRASG12D-mutant pancreatic cancer
    Malak Haidar, Patrick Jacquemin · 2024 · Journal of Gastrointestinal Oncology
  45. Human multiethnic radiogenomics reveals low-abundancy microRNA signature in plasma-derived extracellular vesicles for early diagnosis and molecular subtyping of pancreatic cancer
    Wenjie Shi, Jianying Xu, Yi Zhun Zhu, Chao Zhang, Julia Nagelschmitz, Maximilian Doelling, Sara Al-Madhi, Ujjwal Mukund Mahajan, Maciej Pech, Georg Rose et al. · 2025 · eLife
  46. Dordaviprone/ONC201 Activation of the ClpP Mitochondrial Protease Inhibits the Growth of KRAS-Mutant Pancreatic Cancer and Overcomes RAS Inhibitor Resistance
    Kristina Drizyte‐Miller, Seamus E. Degan, Ryan D. Mouery, Amber M. Amparo, Brandon L. Mouery, Wen-Hsuan Chang, Runying Y. Yang, Sheila R. Nicewarner Peña, Elisa Baldelli, Jeffrey A. Klomp et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  47. Ultrasound-targeted microbubble destruction improves the suppression and magnetic resonance imaging of pancreatic cancer with polyethyleneimine nanogels
    Yang Liu, Yuanqiong Deng, Paul Eugène Constanthin, Fan Li · 2024 · Journal of Cancer
  48. Exploring the clinical significance of TPX2 in pancreatic cancer: from biomarker to immunotherapy
    Zhengguang Zhang, Zixian Liu, Ying Yao, Min Li, Cunsi Shen, Fuqiong Zhou · 2024 · Naunyn-Schmiedeberg s Archives of Pharmacology
  49. Impact of CT-relevant Skeletal Muscle Parameters on Post-chemotherapy Survival in Patients with Unresectable Pancreatic Ductal Adenocarcinoma
    Siying Zhang, Zhenping Wu, Guo Sa, Zhan Feng, Feng Chen · 2025 · Current Medical Imaging Formerly Current Medical Imaging Reviews
  50. Long noncoding HOXD-AS1: a crucial regulator of malignancy
    Xiang-Yuan Tao, Qianqian Li, Shan-Shan Dong, Hui Wang, Yuqing Yang, Yang Xi, Yong Zeng · 2025 · Frontiers in Cell and Developmental Biology
  51. Evaluation of Machine Learning Techniques for Prediction of Breast Cancer
    Jared Tan Yi Hoong, Samuel-Soma M. Ajibade, Muhammed Basheer Jasser, Anwar P. P. Abdul Majeed, David Olayemi Alebiosu, Bayan Issa, Anthonia Oluwatosin Adediran, Charis Shwu Chen Kwan · 2025 · IEEE International Colloquium on Signal Processing & Its Applications (CSPA)
  52. TNFRSF9 Inhibits Pancreatic Cancer Progression by Regulating PAX6-mediated Cell Proliferation, Migration, and Apoptosis
    Xiaorong Liu, Zhaofeng Gao, Minjie Chen, Fei Chen, Xiaoping Li, Lingyu Hu · 2025 · Pancreas
  53. Risk and prognostic factors of survival for patients with pancreatic ductal adenocarcinoma metastasis to lung: a cohort study
    Yi Chen, Xing-Yu Liu, Jun Yu, Jian-Shui Li, Jing-Dong Li, Peng-Sheng Yi, Bin Wu, Guang-Nian Zhang, Da-Wei Deng, Yong Li et al. · 2025 · Frontiers in Oncology
  54. Single-cell and transcriptomic analyses reveal the role of PCDH17 in the non-inflammatory tumor microenvironment of pancreatic cancer
    Yong Sun, Hong Wan, Jie Xiong, Kun Cao, Dashuai Yang, Jun Xing Huang · 2025 · Frontiers in Endocrinology
  55. α-Asarone attenuates tumor-associated macrophages-induced gemcitabine resistance in pancreatic carcinoma via the transforming growth factor-beta 1/growth factor independent 1 axis
    Jiaqi Yu, Yuzhe Xue, Zhaofeng Gao, Lingyu Hu, Xiaorong Liu, Xuesong He, Xiaoguang Wang · 2025 · Anti-Cancer Drugs
  56. SGCD: High‐Resolution Spatial Domain Characterization via Data Interpolation and Cell‐Type Deconvolution
    Tianjiao Zhang, Shenghe Li, Ruolan Zhang, Hongfei Zhang, Zhongqian Zhao, Hao Sun, Zhenao Wu, Guohua Wang · 2025 · Advanced Science
  57. Calliviminone A from Callistemon citrinus Induces PANC-1 Pancreatic Cancer Cell Death by Targeting the PI3K/Akt/mTOR Pathway
    Juthamart Maneenet, Ahmed M. Tawila, Hung Hong Nguyen, Nguyễn Duy Phan, Orawan Monthakantirat, Supawadee Daodee, Chantana Boonyarat, Charinya Khamphukdee, Yaowared Chulikhit, Suresh Awale · 2025 · Plants
  58. The T‐Box Transcription Factors TBX2 and TBX3 Are Molecular Targets of Piroctone Olamine in the Treatment of Pancreatic Cancer
    Karabo Serala, Sanele Mdletshe, Jinming Bai, Amaal Abrahams, Odile Gayet, Loïc Moubri, Nelson Dusetti, Sharon Prince · 2025 · Journal of Cellular and Molecular Medicine
  59. Discovery of compound 1105486 as a selective inhibitor of B4GALT1: potential for pancreatic cancer therapy
    Yunyun Xu, Mou Yiping · 2025 · Frontiers in Chemistry
  60. Antitumor effects and mechanisms of traditional Chinese medicine gamboge: A review
    Yanqing Zhou, Jialing Chen, Qin Zhu, Binyan Lin · 2025 · Frontiers in Pharmacology
  61. Manipulating anthracyclines for deeper tissue penetration and implications for glycolytic tissues
    Erik R. Abels, Esther ter Linden, Jos H. T. Rohling, Lenard M. Voortman, Dennis P. A. Wander, Lennert Janssen, Marten Hornsveld, Herman S. Overkleeft, Sabina Y. van der Zanden, Marike L. D. Broekman et al. · 2025 · Proceedings of the National Academy of Sciences
  62. Multifunctional nanoliposome-loaded hypoxia-activated evofosfamide: improving antitumor activity and ferroptosis in pancreatic adenocarcinoma
    Bo Yi, Haiyang Zhou, Jing Chen, Sun Lei · 2025 · International Journal of Pharmaceutics
  63. USP11 stabilizes RALY to promote FXYD5-mediated aerobic glycolysis and aggravate pancreatic cancer progression
    Hongmin Xie, Langxia Liao, Jiaxuan Li, Runsheng Cai, HongBiao He, Min Lu · 2025 · Experimental Cell Research
  64. Hederagenin exerts anti-tumor effects in pancreatic cancer by impairing DRP1 mediated-mitophagy via VDAC1-HK2-PINK1/PARKIN pathway
    Fang Su, Jianhua Yu, Shenhao Xu, Huanjun Tong, Jiandong Li, Fangfang Tao, Baochun Lu · 2025 · Toxicology and Applied Pharmacology
  65. Wilms Tumor 1–Expressing Stromal Cells Promote Pancreatic Cancer Progression
    Allison C. Bischoff, Kristee L. Brown, E. Lasse-Opsahl, Hannah R. Watkoske, Carlos E. Espinoza, J. Okoye, A. Olivei, Leah M Green, Ridesh Rai, Stephanie The et al. · 2025 · Cancer Research
  66. Steroidal derivatives in pancreatic cancer: Paving the way to new anticancer drugs
    Ana R. Gomes, E. J. Tavares da Silva, Fernanda M.F. Roleira, Ana Salomé Pires · 2025 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  67. Carrier-free single-molecule hypoxia-activated nanoprodrug of SN38 with ultrahigh drug loading for pancreatic cancer treatment
    Amrit Regmi, Mouhmad Elayyan, Safiya Nisar, Binglin Sui · 2025 · Journal of Materials Chemistry B
  68. Lipid Nanoparticle-Mediated RNAi Against GIPC1 Overcomes Chemoresistance in Pancreatic Ductal Adenocarcinoma
    Vijay Sagar Madamsetty, Hari Krishnareddy Rachamala, Shamit Kumar Dutta, Enfeng Wang, Krishnendu Pal, Debabrata Mukhopadhyay · 2025 · Pharmaceutics
  69. Chemotherapy enhances HMGA1 secretion through the mutant p53-CK2 axis in pancreatic ductal adenocarcinoma cells
    Federica Danzi, Giovanna Butera, Damien Sutton, Matthew D. Perricone, Yushu Hu, Adriana Celesia, Marcello Manfredi, Jessica Brandi, Narges Pourmandi, Noah S. Nelson et al. · 2025 · Cell Death and Disease
  70. DKK3 Initially Preserves Acinar Integrity Through MEK‐Fos Signaling, but Later Switches to an Oncogenic Role in Pancreatic Cancer
    Dharini Srinivasan, E. Roger, L. Perkhofer, Eleni Zimmer, T. F. Barth, Julia P Mosler, Anna Härle, S. Weissinger, N. Gaisa, P. Möller et al. · 2025 · Advancement of science
  71. Establishing cancer registries in Africa — focus on hepatopancreatobiliary cancers
    Akwi Wasi Asombang, Samuel O. Antwi, Abidemi E. Emmanuel Omonisi, Matthew A. Cooley, Yvonne Ayerki Nartey, Caitlin J. VanLith, Hailemichael Desalegn, Edith Nonyelum Okeke, Fidel Rubagumya, Albert Théophane Yonli et al. · 2025 · Nature Reviews Gastroenterology & Hepatology
  72. Modulation of Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway in Gastrointestinal Cancers by Phytochemicals
    Pratibha Pandey, Meenakshi Verma, Samra Siddiqui, Ali G. Alkhathami, Mοhd Saeed, Monika Singh, Fahad Khan · 2025 · Pharmaceutical Research
  73. CD47 peptide-albumin cloaked mesoporous silica nanoparticles for enhanced macrophage evasion and synergistic combination therapy
    Iris Pontón, Sandra Núñez, Cristina Díaz‐Perlas, Benjamí Oller‐Salvia, Carlos E. Semino, David Sánchez‐García · 2025 · Journal of Drug Delivery Science and Technology
  74. Complementary strategies in pancreatic cancer precision medicine: therapeutic prediction and immune modulation
    Wonmin Lee, Hyun-Myung Woo, Ja Hyang Cho, Man Soo Kim · 2025 · Frontiers in Oncology
  75. Ferroptosis-induced remodeling of glycosylation the immune microenvironment and improves survival in pancreatic cancer
    Hao Tan, Haitao Zhang, Jiacheng Gao, Lei Wang, Xiaofeng Luan · 2025 · World Journal of Surgical Oncology
  76. Post-Translational Modifications: Key “Regulators” of Pancreatic Cancer Malignant Phenotype—Advances in Mechanisms and Targeted Therapies
    Yongkang Shi, Renyi Qin, Yiming Li · 2025 · Biomedicines
  77. Prognostic biomarker discovery in pancreatic cancer through hybrid ensemble feature selection and multi-omics data
    John Zobolas, Anne-Marie George, A. Lopez, Sebastian Fischer, Marc Becker, Tero A. Aittokallio · 2026 · BioData Mining
  78. Broadening the gates: Analysis of potentially modifiable study entry criteria in pancreatic and biliary tract cancer trials
    Fen Saj, Felicity K. Namayanja, Lianchun Xiao, Mitesh J. Borad, Robin Kate Kelley, Lipika Goyal, Nilofer Saba Azad, Melinda Bachini, Stacie C. Lindsey, Shubham Pant et al. · 2025 · Cancer
  79. Multi‐omics analysis identifies PUS7 as an immune modulator driving NETs‐mediated macrophage polarization in pancreatic cancer
    Jike Fang, Shiye Ruan, Yajie Wang, Yue Chen, Fuxin Huang, Zhongyan Zhang, Chuanzhao Zhang, Baohua Hou, Shanzhou Huang · 2026 · Clinical and Translational Medicine
  80. Modeling CAF-tumor interactions to overcome therapy resistance
    Jakub Gubała, Daniel A. Benamran, Petros K. Tsantoulis, Valentin Mieville, Massimo Valério, Patrycja M. Nowak-Sliwinska · 2026 · Journal of Experimental & Clinical Cancer Research
  81. Prognostic model for pancreatic cancer based on machine learning of routine slides and transcriptomic tumor analysis
    Manabu Takamatsu, Mariko Hori Tanaka, Yohei Masugi, Yosuke Inoue, Hiroko Nagano, Tho Ngoc-Quynh Le, Kenji Nishida, Yui Sawa, Kota Sugiura, Yoshikuni Kawaguchi et al. · 2026 · British Journal of Cancer
  82. Rescue Radiosensitization of Pancreatic Cancer via PD-L1/TGF-β1 Dual-Blockade Nanotherapy as Evaluated in 3-Dimensional Microtumors
    Di Chen, Lei He, Liang Chen, Chen Ye, Fei Duan, Xiaofei Zhu, Wei Jing, Huojun Zhang, Wei Li · 2026 · Biomaterials Research
  83. Pulsed Low-Dose-Rate Chemoradiation Induces Stromal Reprogramming in Pancreatic CAF-Generated ECM: Quantification by the HOST-Factor
    Janusz Franco‐Barraza, Mariia Dmitrieva, Tiffany Luong, Brian Lee Egleston, Kristopher S. Raghavan, Jessica Karen Wong, Debora Barbosa Vendramini Costa, Ralph A. Francescone III, Jaye C. Gardiner, Elizabeth A. Handorf et al. · 2026 · Gastro Hep Advances
  84. Enhancement of gemcitabine toxicity and specificity through PI3K/Akt/Nrf2 pathway inhibition in pancreatic cancer
    Yu-Shan Chen, Steve O’Hagan, Philip J. Day · 2026 · Frontiers in Pharmacology
  85. Toward Timely Diagnosis of Pancreatic Cancer: Revolutionizing Early Detection Through Genomics, Artificial Intelligence, and Noninvasive Biomarkers
    Hussain Ma, Sana Qammar, Ju-Mei Wang, Aoqiang Zhai, Fu‐Yu Li, Hai‐Jie Hu · 2026 · Journal of Gastroenterology and Hepatology
  86. Navigating the complexities of ferroptosis in pancreatic ductal adenocarcinoma: roles, mechanisms and potential applications
    Yurao Xiao, Wenjia Wang, Guihua Wang, Yuhui Liu, Jun Gong · 2026 · Cell Death Discovery
  87. Losartan primes pancreatic tumors for effective exosome-biomimetic chemo-immunotherapy
    Xun Hu, Zihua Wang, Yuting Zhu, Peiqing Ma, Ruiqi Zheng, Xiao Zhi, Hao Yan, Ting Xiao, Jie Tian, Qian Wang · 2026 · Journal of Controlled Release
  88. DPP4 suppresses pancreatic cancer growth by enhancing ferroptosis sensitivity through stabilization of ACSL4
    Xiang Zhou, Lingming Kong, Baofu Zhang, Shicheng Xie, Weiming Wang, Gang Chen · 2026 · Cellular Signalling
  89. The c-Myc-USP14-PFKP axis sustains chemoresistance in pancreatic ductal adenocarcinoma
    Pengyu Wang, Weihua Guo, Yang Yang, Yongjie Xie, Fengyi Yin, Jiaqi Li, Xuejing Shi, 曹佩, Chaozhe Ma, Bowen Ding et al. · 2026 · Drug Resistance Updates
  90. circPLEKHM1 promotes tumor growth and metastasis through enhancing FXR1-mediated protein translation in PDAC
    Y. Yang, Li Zhang, Lanyang Gao, Yue Ming, Tingting Zhang, Zixia Ye, W K Liu, Qunli Xiong, Xiaoming Xu, Fuyan Xu et al. · 2026 · Cancer Letters
  91. Cannabigerol induces endoplasmic reticulum stress-mediated apoptosis and ferroptosis via the IRE1α-XBP1 axis in human pancreatic cancer cells
    Ju-Hee Park, Do-Yeon Kim, Han-Heom Na, Tae-Hyung Kwon, Jin-Sung Park, Young Taek Oh, Keun‐Cheol Kim · 2026 · Free Radical Biology and Medicine
  92. A coumarin-based fluorescent probe for viscosity imaging: photophysical characterization and applications in living cells
    Chenxi Du, Yanru Zhang · 2026 · Analytica Chimica Acta
  93. Multitarget microRNA sponge for pancreatic ductal adenocarcinoma: Simultaneous targeting of miR-21, miR-155, and miR-18a
    Mahdi Karimi, Nasrin Motamed, Alireza Shafizadeh, Pedram Mardani, Ehsan Arefian · 2026 · Journal of Pharmacology and Experimental Therapeutics
  94. TRIM29 promotes pancreatic cancer MVI via IκBα K48-ubiquitination and NF-κB activation in CXCL5⁺ epithelial cells
    Liu Long, Zhenzhen Gao, Wang Qi, Xiaohong Zhao, Fabiao Zhang, Zhu Yu, Wangyang Sun, Yuxi Huang, Zhenbo Wang, Sheng Yan et al. · 2026 · Molecular Cancer
  95. Gemcitabine-loaded nanoparticles for pancreatic cancer: from mechanistic innovations to clinical translation
    Sonam Chosdon, Muskan Leharwani, Taha Alqahtani, Humood Al Shmrany, Garima Gupta, Khang Wen Goh, Amirhossein Sahebkar, Prashant Kesharwani · 2026 · International Journal of Pharmaceutics
  96. A comprehensive review of continuous glucose monitoring: innovations, challenges, and future directions in diabetes management
    Kyrillos K. Selim, Adham Farag, Sameh Osama Abdellatif · 2026 · Microsystem Technologies
  97. Multimodal transcriptomics reveal myCAF-derived collagen signaling associated with impaired NK-cell cytotoxicity and immune exclusion in pancreatic cancer
    Lei Kong, Shengxin Gu, Mingyang Wang, Lili Gao, Xiaoling Song, Jun Gu · 2026 · Journal of Translational Medicine
  98. Autophagy Inhibition Reprograms the Tumor Microenvironment of Pancreatic Cancer to Promote Macrophage Phagocytosis of Tumor Cells
    Elaine Y. Lin, Subhadip Mukhopadhyay, Deborah Corcoran, Mohamad Assi, Joel Encarnación-Rosado, Albert S.W. Sohn, Douglas E. Biancur, Peter Y. Yu, Jiehui Deng, Ting Chen et al. · 2026 · Cancer Research
  99. Targeted extracellular vesicle-photoimmunotherapy remodels stromal-immune microenvironment to boost chemo-immunotherapy in preclinical models
    Chengming Qu, Jie Liu, Jinpeng Cen, Ming Tian, Yibo Chai, Peng Xia, Runhua Zhou, Jingbo Ma, H Wang, Haitao Yuan et al. · 2026 · Cell Reports Medicine
  100. Impact of initial severity and progression pattern of new-onset diabetes on pancreatic cancer risk: a 15-year longitudinal nationwide cohort study
    Minyoung Lee, Min Heui Yu, Wonjeong Chae, Yong‐ho Lee, B I Lee, Eun Seok Kang, Bong‐Soo Cha, Sung‐In Jang, Moon Jae Chung · 2026 · Gut